Topic Listing for LABORATORY CORP OF AMERICA HOLDINGS

Abu Dhabi Knee Sports Medicine Centre Abu Dhabi Spine Centre
Acceleration Accns
Accounts Investments Accounts Receivable Net
Accruals Self-insurance Reserves Accrued Expenses Other
Accumulated Other Comprehensive Earnings Actions Binding Future Securityholders
Actions Successor Additional Information
Adjusted Measures Administration
Adverse Results Material Litigation Matters Effect Business Agreed Accepted
Agreement Part Program Agreement Participant Regarding Withholding Taxes
Allergy Testing Allowance Doubtful Accounts
Allowances Doubtful Accounts Amendment
Amendment Laboratory Corporation America Holdings Amendment New Pension Equalization Plan
Amendment Performance Award Agreement Dated 2005 Amendment Termination Committee
Amendment Termination Plan Compliance 162 Amendments
Amendments Articles Incorporation By-laws Change America Holdings
America Holdings 1995 Stock Plan Non-employee Directors Amortization Intangibles Other Assets
Amount Severance Announces 2008 Full Results
Announces 2008 Results Announces 2009 Results
Annual Compensation Appendix
Application Trust Money Appointment Fill Vacancy Office Trustee
Arzanah Medical Diagnostic Centre Audit Committee
Audit Committees Report Authenticating Agent
Awards Bad Debt Expense
Bad Debt Rate Approximately Sales Base Salary
Basis Financial Statement Presentation Become Laboratory Choice Managed Care
Beneficial Ownership Reporting Compliance Benefit Levels
Benefits Indenture Billing
Board Directors Board Directors Committees
Board Directors Recommends Stockholders Vote Election Each Nominees Board Evaluation
Bonus Breach Special Severance Agreement
Burlington Burlington 2008
Burlington 2009 Burlington 2009 8212
Burlington Rockville 2008 Business Acquisition Dianon Systems Inc
Business Acquisition Dynacare Inc Business Acquisitions
Business Harmed Loss Suspension License Imposition Fine Penalties California Rel Hunter Laboratories Llc Quest Diagnostics Incorporated
Cancellation Cancer Diagnostics
Capitalize Unique Opportunities New Testing Technologies Capitalized Software Costs
Capitated Cardiovascular Disease
Cash Equivalents Cause
Cautionary Regarding Forward-looking Statements Celera Labcorp Announce Licensing Agreement Commercialize Breast Cancer
Ceo Retirement Certain Relationships Related Transactions
Certain Relationships Related Transactions Director Independence Certain Securities Owned Disregarded
Changes Federal State Local Third-party Payer Regulations Policies Changes Internal Control Over Financial Reporting
Changes Payer Mix Including Increase Capitated Managed-cost Health Changes Reimbursement Foreign Governments Currency Exchange Fluctuations Adverse
Changes Securities Proceeds Issuer Purchases Equity Claims Benefits Review Denials
Claims Procedure Cleveland Clinic Abu Dhabi
Client Clients
Clinical Laboratory Testing Industry Clinical Laboratory Testing Industry Competition
Clinical Laboratory Testing Market Annually Clinical Trials Testing
Code Ethics Experts Audit Committee Collection Suit Trustee
Commitments Contingencies Committee Membership
Committee Powers Authority Duties Responsibilities Common Shares Held Treasury
Common Shares Issued Common Stock Performance
Communications Board Compared 2002
Compared 2003 Compared 2004
Compared 2005 Compared 2006
Compared 2007 Comparison Cumulative Total Return
Compensation Committee Compensation Committee Interlocks Insider Participation
Compensation Committee Report Compensation Committee Report Executive
Compensation Directors Compensation Indemnity
Compensation Plans Arrangement Competition
Compliance Certificate Compliance Certificates Opinions
Compliance Hipaa Security Regulations Privacy Increase Costs Compliance Program
Compromise Concentration Credit Risk
Conclusion Regarding Effectiveness Disclosure Controls Procedures Conditions Defeasance
Confidential Confidentiality
Conflict Trust Indenture Act Consent Independent Registered Public Accounting Firm
Consolidated Financial Statements Statement Schedule Continuation Benefits
Contractual Cash Obligations Contributions Vesting
Control Majority Controlled Substances
Controls Procedures Conversion Right Triggered Labcorps Liquid Yield Option Notes
Copy Core
Corporate Governance Guidelines Code Business Conduct Ethics Corporate News
Cost Sales Counterparts
Coupon Convertible Subordinated Notes Coupon-subordinated Notes
Covered Employee Covered Employees
Credit Facilities Credit Facility
Credit Ratings Critical Accounting Policies
Cross-reference Table Current Report
Cusip Numbers Customer Interaction
Customer Retention Cytyc Thinprep Imaging System
Date Results Debt
Debt Issuance Costs Deemed Owners
Defeasance Deferred Compensation Plan
Defined Terms Definitions
Denominations Provisions Payment Denver Burlington 2008
Departure Directors Certain Officers Election Appointment Compensatory Deposit Redemption Price
Derivative Financial Instruments Designated Group
Designation Terms Securities Develop Market New Tests
Development New Tests Diagnostic Genetics
Diluted Esp Guidance Excludes Impact Exchange Lyons Notes Director Whose Term Office Expiring
Directors Directors Executive Officers Corporate Governance
Directors Executive Officers Registrant Disclosure Controls Procedures
Discontinuation Recalls Existing Testing Products Failure Develop Acquire Discount Rate
Discussion Federal Income Tax Consequences Distribution Account
Dividends Documents Included Disclosure Package Initial Sale Time
Documents Incorporated Reference Draft Guidance Industry Clinical Laboratories Fda Staff Vitro
Drug Testing Duke Institute Genome Sciences Policy
Duties Trustee Duty Cooperate
Duty Loyalty Nondisparagement Duty Mitigate
Earnings Per Share Effect Certain Changes
Effect Headings Effect Market Changes Clinical Laboratory Business
Effect Notice Redemption Effect Successors Assigns
Effect Supplemental Indentures Effectiveness Approval Stockholders
Efficiencies Electronic Delivery Proxy Materials
Eligibility Eligibility Disqualification
Eligibility Participation Eligibility Payment Awards
Employee Employee Nonqualified Stock Options
Employee Stock Purchase Plan Employees
Employment Separation Agreement General Release Entry Material Definitive Agreement
Environmental Health Safety Eps
Eps Increases 155 Percent 067 Ebitda Margin Hits Equity Compensation Plan Information
Estimate Implementation Required Change Accounting Stock Based Compensation Estimates
Ethics Quality Assurance Committee Events Default
Evidence Action Securityholders Exact Name Registrant Specified Charter
Exchange Act Exchange Offer Zero-coupon Subordinated Notes
Execution Authentication Execution Supplemental Indentures
Executive Compensation Executive Officers
Executive Retirements Expand Leverage National Infrastructure
External Accreditation Face Significant Monetary Damages Penalties Exclusion Medicare Medicaid
Failure Comply Environmental Health Safety Laws Regulations Including Failure Comply Sarbanes-oxley Act 2002 Including 404 Requires
Failure Develop Acquire Licenses New Improved Testing Technologies Failure Information Technology Systems Significantly Increase Testing Turn-around
Failure Integrate Newly Acquired Businesses Costs Related Such Failure Obtain Retain New Customers Alliance Partners Loss
Failure Obtain Retain New Customers Alliance Partners Reduction Fair Value Financial Instruments
Fair Value Measurements Fee Service
Filed 2007 Financial Achievements
Financial Guidance Financial Guidance 2005
Financial Guidance 2005 Contd Financial Guidance 2008
Financial Guidance 2009 Financial Measures
Financial Performance Financial Statement Revision
Financial Statements Exhibits Financial Statements Supplementary Data
Financing Activities Five-year Revenue Eps Trend
Focus Focus Providing Value Shareholders
Focus Returning Value Shareholders Form 10-k
Form 10-q Form Opinion General Counsel
Form Opinion Hogan Hartson Llp Counsel Form Securities Trustees Certificate
Forward-looking Statements Fraud Abuse Laws Regulations
Free Cash Flow Investment Strategy Full Financial Achievements
Full Results Full-year Financial Achievements
Furnish Trustee Names Addresses Securityholders Further Instruments Acts
Further Operational Efficiencies Gender Number
General General Delegation
General Provisions Genomic
Genomic Esoteric Global Securities
Goodwill Intangible Assets Governing Law
Gross-up Excise Tax Headings
Histology Hmos Other Managed Care Groups
Holders Hospital Market
Hospital Portal System Now Includes Clinical Laboratory Component Hospitals
Householding Identification Evaluation Individual Director Candidates
Identifies Genetic Variants Drug-metabolizing Enzymes Help Physicians Manage Identity Testing
Immediate Release Inability Attract Retain Experienced Qualified Personnel Adversely Affect
Incentive Stock Options Income Joint Venture Partnerships
Income Tax Expense Income Taxes
Incorporation Reference Increased Competition Including Price Material Adverse Impact Net
Incumbent Board Indemnification
Indemnity Governmental Obligations Independence Standards
Independent Physicians Physician Groups Index
Individual Rights Trustee Infectious Disease
Information Please Contact Information Systems
Intangible Assets Integral Quality Healthcare
Integration Dynacare Dianon Interest Expense
Interest Rate Swap Agreements Internal Control Over Financial Reporting
Internal Control-integrated Framework Internal Proficiency Testing
Interpretation Enforcement Introduction
Inventories Investing Activities
Investment Loss Investments Joint Venture Partnerships
Investorlabcorpcom Issuer Purchases Equity Securities
Labcorp Labcorp Announces 500 Stock Repurchase Program
Labcorp Announces Availability Affymetrix-based Whole Genome Microarrays Labcorp Announces Availability Colosure
Labcorp Announces Availability Ovasure Ovarian Cancer Test High-risk Labcorp Announces Collaboration Kannapolis-based Biorepository
Labcorp Announces Contract Extension Cigna Healthcare Labcorp Announces David King Elected Chairman Board
Labcorp Announces Definitive Agreement Acquire Esoterix Inc Subsidiaries Labcorp Announces Definitive Agreement Acquire Tandem Labs Inc
Labcorp Announces Proposed Sale 250 Senior Notes Due Labcorp Announces Stock Repurchase Program
Labcorp Arca Discovery Partner Commercialize Companion Diagnostic Cardiovascular Labcorp Begin Validation Evaluation Roche Diagnostics Amplichip Cyp450
Labcorp Commercially Launch Gene Methylation Test Prostate Cancer Labcorp Completes Acquisition Esoterix Inc
Labcorp Completes Acquisition Pathology Labs Inc Labcorp Duke University Collaborate Offer New Genomic Tests
Labcorp Enters New Credit Facilities Totaling Labcorp Exclusively Licenses Yale Technology New Early Stage
Labcorp Launches Comparative Genomic Hybridization Testing Labcorp Launches Elabcorp Web-based Customer Connectivity Solution
Labcorp Launches Integrated Sequential Prenatal Screening Technology Down Labcorp Licenses Arcturus Technology Characterization Tumor Cells Unknown
Labcorp Licenses Gene Methylation Technology Prostate Cancer Veridex Labcorp Licenses Technology Early Detection Lung Cancer Duke
Labcorp Medicity Inc Partner Offer Secure Web-based Computer Labcorp Names Chief Operating Officer
Labcorp Notified Aetna Contract Termination Labcorp Present Jpmorgan Healthcare Conference
Labcorp Present Lehman Brothers Global Healthcare Conference Labcorp Present Merrill Lynch Health Services Conference
Labcorp Present Ubs Global Healthcare Services Conference Labcorp Present Ubs Global Life Sciences Conference
Labcorp Prices 250 Senior Notes Due 2015 Labcorp Scheduled Present 18th Annual Wachovia Nantucket Equity
Labcorp Scheduled Present 25th Annual Jpmorgan Healthcare Conference Labcorp Scheduled Present Banc America Securities Healthcare Conference
Labcorp Scheduled Present Bank America 2007 Health Care Labcorp Scheduled Present Bank America 2007 Investment Conference
Labcorp Scheduled Present Bank America 2008 Health Care Labcorp Scheduled Present Bank America 36th Annual Investment
Labcorp Scheduled Present Bank America Annual Investment Conference Labcorp Scheduled Present Bank America Health Care Conference
Labcorp Scheduled Present Bear Stearns 2007 Healthcare Conference Labcorp Scheduled Present Cowen Annual Global Health Care
Labcorp Scheduled Present Cowen Annual Health Care Conference Labcorp Scheduled Present Cowen Annual Healthcare Conference
Labcorp Scheduled Present Credit Suisse 2007 Global Healthcare Labcorp Scheduled Present Jefferies 2007 Healthcare Conference
Labcorp Scheduled Present Jpmorgan Healthcare Conference Labcorp Scheduled Present Lehman Brothers 2007 Global Healthcare
Labcorp Scheduled Present Lehman Brothers 2008 Global Healthcare Labcorp Scheduled Present Merrill Lynch Health Services Investor
Labcorp Scheduled Present Piper Jaffray Health Care Conference Labcorp Scheduled Present Susquehanna Financial Group Significant Investment
Labcorp Scheduled Present Thomas Weisel Partners Healthcare Conference Labcorp Scheduled Present Ubs 2007 Global Life Sciences
Labcorp Scheduled Present Ubs 2008 Global Life Sciences Labcorp Scheduled Present Ubs Global Healthcare Services Conference
Labcorp Scheduled Present Ubs Global Life Sciences Conference Labcorp Scheduled Present Wachovia Securities 2007 Healthcare Conference
Labcorp Scheduled Present Wachovia Securities 2008 Healthcare Conference Labcorp Scheduled Webcast Annual Meeting Stockholders
Labcorp Selected Exclusive National Laboratory Unitedhealthcare Also Develop Labcorp Strengthen Leadership Infectious Disease Oncology Advance Personalized
Labcorp Total Labcorp Total Canada
Labcorps Investment Performance Fundamentals Labcorps Liquid Yield Option Notes Accrue Contingent Cash
Labcorps Liquid Yield Option Notes Due 2021 Convertible Labcorps Liquid Yield Option Notes Due 2021 Coupon
Laboratory Corporation America Laboratory Corporation America Announces 2005 Results
Laboratory Corporation America Enters New 350 Revolving Credit Laboratory Corporation America Holdings
Laboratory Corporation America Holdings 358 South Main Street Laboratory Corporation America Holdings Agrees Acquire Dsi Laboratories
Laboratory Corporation America Holdings Amendment 2008 Stock Incentive Laboratory Corporation America Holdings Announces Appointment David King
Laboratory Corporation America Holdings Announces Final Results Exchange Laboratory Corporation America Holdings Subsidiaries
Laboratory Corporation America Holdings Subsidiaries Index Consolidated Financial Laboratory Corporationof America Holdings Registrant
Laboratory Testing Operations Services Legal Proceedings
Leroy Hood Labcorp Establish Collaborative Relationship Level
Limitation Amount Severance Pay Limitation Liens
Limitation Rights Limitation Sale Leaseback Transactions
Limitation Subsidiary Indebtedness Preferred Stock Limitation Suits
Liquidity Capital Resources Financial Position Long-lived Assets
Long-term Debt Long-term Incentive Plans Performance Share Grants 2005
Mac Mahon Remain Chairman Board Directors Until 2008 Maintenance Corporate Existence
Maintenance Office Agency Registration Transfer Exchange Payment Managed Care
Managements Report Internal Control Over Financial Reporting Market Information
Market Registrants Common Equity Related Stockholder Matters Issuer Master Senior Executive Severance Plan
Material Modification Rights Security Holders Maturity Date Shall Mean 2012
Medco Medco Labcorp Strike Strategic Agreement Research Personalized Medicine
Medicare Medicaid Meetings Stockholders
Merge Transfer Assets Mib Bonus
Minhaal Minority Interest Put
Miscellaneous Monogram Biosciences Inc
Mubadala Development Mutilated Destroyed Lost Stolen Securities
Name Person Filing Proxy Statement Other Registrant National Jewish Health
Nch Healthcare System New Accounting Pronouncements
New Pension Equalization Plan New Plan Benefits Laboratory Corporation America Holdings 1995
New Test Format Help Doctors Tailor Patient Treatment New Tool Signature Genetics Drug Response Interpretation Service
New York 10019 News World Report
Ngi Viromed Industry Forces Nine-month Financial Achievements
Nine-month Results Nominating Corporate Governance Committee
Nominees Election Directors Non-gaap Measures
Non-solicitation Non-compete Noncontrolling Interest Put
Notes Financial Tables Notice Defaults
Notice Redemption Notices
Notices Trustee Occupational Testing Services
Ocf Cagr Ebitda Margin Growth 210 Bps Off-balance Sheet Arrangements
Officers Officers Certificate
Oncology Testing Oncomethylome Sciences Grants Commercial License Labcorp Mgmt Methylation
Operating Activities Operations Disrupted Adversely Impacted Effects Natural Disasters Such
Option Exercises Stock Vested Option Sar Grants 2004
Option Sar Grants 2005 Other Business
Other Commercial Commitments Other Esoteric
Other Events Other Institutions
Other Liabilities Other Remedies
Outlook 2008 Outlook 2008 2009
Outlook 2009 Outstanding Liquid Yield Option Notes Due 2021
Outstanding Securities Ovasure Ovarian Cancer Testing Service High-risk Women
Pap Tests Important Ever Battle Against Disease Part
Part Financial Information Part Other Information
Patient Payers
Payment Clinical Laboratory Services Payment Consent
Payment Securities Payments Business
Pension Expense Pension Funding
Pension Plan Table Pension Postretirement Plans
Pep Plan Payments Subject 409 Irc Require Six-month Performance Awards
Performance Share Awards Performance Share Grants 2005
Person Phase Results Yales Early Stage Ovarian Cancer Blood
Plan Plan Not Funded
Post-retirement Medical Plan Preferential Collection Claims Against
Preferred Stock Common Shareholders Equity Preliminary Financial Guidance 2006
Preservation Information Communications Securityholders Price Volumes Trends Payer Type
Primary Testing Locations Principal Accountant Fees Services
Priorities Professional Liability
Profile Labcorp Proof Execution Securityholders
Properties Property
Property Plant Equipment Property Plant Equipment Net
Proposal Amendment 1997 Employee Stock Purchase Plan Proposal Approval Management Incentive Bonus Plan
Proposal Election Directors Proposal Ratification Independent Registered Public Accounting Firm
Proposed Acquisition Proprietary Service Helps Physicians Cyp450 Information Customize Medications
Provision Paying Agent Provisions Applicable Covered Officers
Proxy Statement Proxy Statement Pursuant Securities Exchange Act 1934
Purchases 250 Common Stock Accelerated Share Repurchase Agreement Purpose
Purpose Plan Purpose Restrictions Amount Available Plan
Pursuant Securities Exchange Act 1934 Quality
Quality Assurance Quality Compliance Committee
Quality Control Quantitative Qualitative Disclosure Market Risk
Quarterly Data Qui Tam
Real-time Pcr Test Quickly Detects Differentiates H5n1 Avian Receipt Confidential Information
Reclassifications Reconciliation Non-gaap Financial Measures
Recourse Redemption
Reemployment Registrants Business Operations
Registration Transfer Exchange Regulation Clinical Laboratories
Regulation Disclosure Regulations
Regulations Requiring Standard Transactions Health Care Services Issued Reimbursement Services Adversely Impacted Due Failure Covered Health
Reinstatement Related Party Transactions
Related Persons Transactions Release
Repayment Replacement Trustee
Report Independent Registered Public Accounting Firm Report Management Internal Control Over Financial Reporting
Reports Reports Trustee Holders
Repurchased Approximately 108 Labcorp Stock Repurchased Approximately 1113 Labcorp Stock
Repurchased Approximately 665 Labcorp Stock Research Development
Restricted Shares Stock Units Restricted Stock
Restricted Stock Awards 2005 Restricted Stock Grants 2004
Restricted Stock Grants 2005 Restricted Stock Performance Shares
Restructuring Charges Restructuring Other Special Charges
Restructuring Reserves Results
Results Operations Retention
Retirement Benefits Retirement Benefits Savings Plan
Return Plan Assets Return Property
Revenue Growth Drives Operating Cash Flow 1786 Revenue Recognition
Revenue Recognition Allowance Doubtful Accounts Revolutionary Procedure Helps Identify Newly Infected Hiv Patients
Revolving Credit Facility Right Amend Terminate
Rights Holders Receive Payment Rights Test Ugt1a1 Mutations Associated Serious Adverse Reaction
Rights Trustee Risks Associated Business
Routine Testing Sales Marketing Client Service
Satisfaction Discharge Schedule
Scientific Differentiation Seasonality
Securities Affected Supplemental Indentures Securities Authorized Issuance Equity Compensation Plans
Securities Exchange Act 1934 Securities Redeemed Part
Securities Trading Markets Security Ownership Certain Beneficial Holders Management
Security Ownership Certain Beneficial Owners Management Security Ownership Certain Beneficial Owners Management Related Stockholder
Selection Securities Redeemed Selling General Administrative Expenses
Senior Credit Facilities Senior Notes
Senior Notes Due 2013 Senior Notes Due 2015
Separability Separation Pay
Seq Seryx
Severance Pay Shall Delivered Trustee Depositary Pursuant Depositarys Instruction
Share Repurchase Program Short-term Investments
Signatures Significant Deterioration Economy Negatively Impact Testing Volumes Cash
Significant Increase Sales Outstanding Levels Bad Debt Expense Six-month Financial Achievements
Solicitation Voting Proxies Revocation Record Date Source Cms Office Actuary G-2 Estimates
Source Estimates Industry Reports 2004 Revenue Labcorp Source Estimates Industry Reports 2005 Revenue Labcorp
Special Provisions Relating Covered Officers Specialty Niche Testing
Specialty Testing Specimen Management
Standard Electronic Transactions Security Confidentiality Health Information Standardized Platforms
Statement Computation Ratios Earnings Fixed Charges Statement Person Making Such Certificate Opinion Read Covenant
Status Covered Employee Stock
Stock Appreciation Rights Stock Compensation Plans
Stock Option Transactions 2004 Stock Option Transactions 2005
Stock Options Stock Plan Non-employee Directors
Stock Price Annual Meeting Date Stock Repurchase Program
Stock Splits Stockholder Proposals
Stockholder Rights Plan Stockholders Laboratory Corporation America Holdings
Strategy Submission Matters Vote Security Holders
Subsequent Event Successor Trustee Merger
Supplemental Cash Flow Information Supplemental Indentures Consent Securityholders
Supplemental Indentures Without Consent Securityholders Supplemental Terms Notice Enhanced Overnight Share Repurchase
Surrender Powers Systems
Tawam Molecular Imaging Centre Tax Withholding
Temporary Securities Term
Term Plan Termination
Termination Amendment Terms Conditions Options
Testing Services Thomas Mac Mahon Chairman Chief Executive Officer Annual
Title Total Managed Care
Treatment Securities Debt Trust
Trustee Proofs Claim Trustees Disclaimer
Undertaking Costs United Healthcare Contract
Updated 2005 Financial Guidance Vanda Pharmaceuticals Inc
Via E-mail Regular Mail Waiver Past Defaults
Waiver Stay Extension Laws Williams Had Involvement Negotiations Leading Agreement Was Recused
Women Benefit Scientific Technological Advancements Detect Prevent Treat Yale Office Cooperative Research
Year-end 2004 Option Sar Values Year-end 2005 Option Sar Values
Ytd Zero-coupon Convertible Subordinated Notes
Zero-coupon Subordinated Notes 
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki